F9 and cancer: To further determine if there is a wider implication for F9 loss-of-function in other types of cancers, we tested a panel of 22 cancer cell lines from different origins and molecular characteristics with increasing concentrations of Palbo, Abema and Ribo (Fig. 5A, Fig. S5A).